NEW YORK (Reuters Health) – New research from Japan suggests that antenatal corticosteroids promote survival in extremely preterm infants born at 22 to 23 weeks gestation. Based on…
NEW YORK (Reuters Health) – Clinical outcomes are no better or worse when nulliparous women with an unfavorable cervix at term have elective induction of labor compared to…
NEW YORK (Reuters Health) – Wound complications occur twice as often when transverse cesarean sections are closed with staples rather than subcuticular sutures, the results of a meta-analysis…
NEW YORK (Reuters Health) – Methylene blue has certain advantages over isosulfan blue in sentinel lymph node procedures, but the risk of a palpable mass at the injection…
NEW YORK (Reuters Health) – Women undergoing emetogenic surgical procedures are less likely to have postoperative nausea and vomiting when treated with ondansetron plus casopitant than with ondansetron…
NEW YORK (Reuters Health) – The majority of women who become pregnant after in vitro fertilization (IVF) receives progesterone throughout the first trimester, but that may not be…
NEW YORK (Reuters Health) – Oral contraceptives are just as effective as a gonadotropin-releasing hormone (GnRH) agonist for relieving pelvic pain due to endometriosis, results of a small…
NEW YORK (Reuters Health) – For women with thyroid cancer treated with radioiodine-131, subsequent pregnancy is safe without adverse outcomes for the offspring. That’s according to a report…
NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team…
NEW YORK (Reuters Health) – An interval of no more than 14 days between ultrasonograms in monochorionic twins appears to increase detection of twin-to-twin transfusion syndrome (TTTS), researchers…